These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 8921896
41. The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS. Urushitani M, Ezzi SA, Matsuo A, Tooyama I, Julien JP. FASEB J; 2008 Jul; 22(7):2476-87. PubMed ID: 18337461 [Abstract] [Full Text] [Related]
42. Development of diabetes in a familial amyotrophic lateral sclerosis patient carrying the I113T SOD1 mutation. Case Report. Hamasaki H, Takeuchi Y, Masui Y, Ohta Y, Abe K, Yoshino H, Yanai H. Neuro Endocrinol Lett; 2015 Jul; 36(5):414-6. PubMed ID: 26707039 [Abstract] [Full Text] [Related]
43. Variable metallation of human superoxide dismutase: atomic resolution crystal structures of Cu-Zn, Zn-Zn and as-isolated wild-type enzymes. Strange RW, Antonyuk SV, Hough MA, Doucette PA, Valentine JS, Hasnain SS. J Mol Biol; 2006 Mar 10; 356(5):1152-62. PubMed ID: 16406071 [Abstract] [Full Text] [Related]
45. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Frutiger K, Lukas TJ, Gorrie G, Ajroud-Driss S, Siddique T. Amyotroph Lateral Scler; 2008 Jun 10; 9(3):184-7. PubMed ID: 18574763 [Abstract] [Full Text] [Related]
46. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA. Wang J, Xu G, Slunt HH, Gonzales V, Coonfield M, Fromholt D, Copeland NG, Jenkins NA, Borchelt DR. Neurobiol Dis; 2005 Dec 10; 20(3):943-52. PubMed ID: 16046140 [Abstract] [Full Text] [Related]
47. Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative stress and cell death induced by hydrogen peroxide, 4-hydroxynonenal or serum deprivation: potentiation of injury by ALS-related mutant superoxide dismutases and protection by Bcl-2. Lee M, Hyun DH, Halliwell B, Jenner P. J Neurochem; 2001 Jul 10; 78(2):209-20. PubMed ID: 11461956 [Abstract] [Full Text] [Related]
49. A systematic immunoprecipitation approach reinforces the concept of common conformational alterations in amyotrophic lateral sclerosis-linked SOD1 mutants. Fujisawa T, Yamaguchi N, Kadowaki H, Tsukamoto Y, Tsuburaya N, Tsubota A, Takahashi H, Naguro I, Takahashi Y, Goto J, Tsuji S, Nishitoh H, Homma K, Ichijo H. Neurobiol Dis; 2015 Oct 10; 82():478-486. PubMed ID: 26297318 [Abstract] [Full Text] [Related]
51. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS. Ince PG, Tomkins J, Slade JY, Thatcher NM, Shaw PJ. J Neuropathol Exp Neurol; 1998 Oct 10; 57(10):895-904. PubMed ID: 9786240 [Abstract] [Full Text] [Related]
52. The p.E22G mutation in the Cu/Zn superoxide-dismutase gene predicts a long survival time: clinical and genetic characterization of a seven-generation ALS1 Spanish pedigree. Syriani E, Morales M, Gamez J. J Neurol Sci; 2009 Oct 15; 285(1-2):46-53. PubMed ID: 19524271 [Abstract] [Full Text] [Related]